PHOSPHO1 Serves as a Key Metabolism-Related Biomarker in the Tumorigenesis of Diffuse Large B-cell Lymphoma

Abstract

Objective

Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma. Due to its genetic heterogeneity and abnormal metabolism, many DLBCL patients have a poor prognosis. This study investigated the key metabolism-related genes and potential mechanisms.

Methods

Differentially expressed genes, differentially expressed transcription factors (TFs), and differentially expressed metabolism-related genes (DEMRGs) of glucose and lipid metabolic processes were identified using the edgeR package. Key DEMRGs were screened by Lasso regression, and a prediction model was constructed. The cell type identification by estimating relative subsets of RNA transcripts algorithm was utilized to assess the fraction of immune cells, and Gene Set Enrichment Analysis was used to determine immune-related pathways. A regulatory network was constructed with significant co-expression interactions among TFs, DEMRGs, immune cells/pathways, and hallmark pathways.

Results

A total of 1551 DEMRGs were identified. A prognostic model with a high applicability (area under the curve=0.921) was constructed with 13 DEMRGs. Tumorigenesis of DLBCL was highly related to the neutrophil count. Four DEMRGs (PRXL2AB, CCN1, DECR2 and PHOSPHO1) with 32 TF—DEMRG, 36 DEMRG—pathway, 14 DEMRG—immune-cell, 9 DEMRG—immune-gene-set, and 67 DEMRG—protein-chip interactions were used to construct the regulatory network.

Conclusion

We provided a prognostic prediction model based on 13 DEMRGs for DLBCL. We found that phosphatase, orphan 1 (PHOSPHO1) is positively regulated by regulatory factor X5 (RFX5) and mediates MYC proto-oncogene (MYC) targeting the V2 pathway and neutrophils.

References

[1] ChapuyB, StewartC, DunfordAJ, et al.. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med, 2018, 24(5): 679-690

[2] NareshKN. Genetics of Diffuse Large B-Cell Lymphoma. New Engl J Med, 2018, 379(5): 493

[3] GribbenJG, FowlerN, MorschhauserF. Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma. J Clin Oncol, 2015, 33(25): 2803-2811

[4] CoiffierB, LepageE, BriereJ, et al.. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New Engl J Med, 2002, 346(4): 235-242

[5] GlassB, ZiepertM, ReiserM, et al.. High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. Ann Oncol, 2010, 21(11): 2255-2261

[6] HanahanD, WeinbergRA. Hallmarks of cancer: the next generation. Cell, 2011, 144(5): 646-674

[7] BaenkeF, PeckB, MiessH, et al.. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech, 2013, 6(6): 1353-1363

[8] TomczakK, CzerwinskaP, WiznerowiczM. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn), 2015, 19(1A): A68-A77

[9] ArdlieKG, DeLucaDS, SegreAV, et al.. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science, 2015, 348(6235): 648-660

[10] LiberzonA, BirgerC, ThorvaldsdottirH, et al.. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst, 2015, 1(6): 417-425

[11] ZhengR, WanC, MeiS, et al.. Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res, 2019, 47(D1): D729-D735

[12] HarrisMA, ClarkJ, IrelandA, et al.. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res, 2004, 32: D258-D261 Databasic issue

[13] MengT, HuangR, JinJ, et al.. A comparative integrated multi-omics analysis identifies CA2 as a novel target for chordoma. Neuro-oncology, 2021, 23(10): 709-722

[14] YuGC, WangLG, HanYY, et al.. ClusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. Omics, 2012, 16(5): 284-287

[15] GuoH, WangS, JuM, et al.. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis. Front Cell Dev Biol, 2021, 9: 642724

[16] SubramanianA, NarayanR, CorselloSM, et al.. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell, 2017, 171(6): 1437-1452

[17] UhlenM, FagerbergL, HallstromBM, et al.. Proteomics. Tissue-based map of the human proteome. Science, 2015, 347(6220): 1260419

[18] SnelB, LehmannG, BorkP, et al.. STRING: a webserver to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res, 2000, 28(18): 3442-3444

[19] BlazewiczSJ, BarnardRL, DalyRA, et al.. Evaluating rRNA as an indicator of microbial activity in environmental communities: limitations and uses. Isme J, 2013, 7(11): 2061-2068

[20] BrandmanO, HegdeRS. Ribosome-associated protein quality control. Nat Struct Mol Biol, 2016, 23(1): 7-15

[21] PoulosTL. Heme enzyme structure and function. Chem Rev, 2014, 114(7): 3919-3962

[22] AcharyaKR, AckermanSJ. Eosinophil granule proteins: form and function. J Biol Chem, 2014, 289(25): 17406-17415

[23] DuncanT, TrewickSC, KoivistoP, et al.. Reversal of DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci USA, 2002, 99(26): 16660-16665

[24] Di StefanoL, JensenMR, HelinK. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J, 2003, 22(23): 6289-6298

[25] Garcia-MoralesE, Lazaro-MartinezJL, Martinez-HernandezD, et al.. Impact of diabetic foot related complications on the Health Related Quality of Life (HRQol) of patients—a regional study in Spain. Int J Low Extrem Wounds, 2011, 10(1): 6-11

[26] BrandK. Glutamine and Glucose-Metabolism during Thymocyte Proliferation - Pathways of Glutamine and Glutamate Metabolism. Biochem J, 1985, 228(2): 353-361

[27] AdamsHJ, de KlerkJM, FijnheerR, et al.. Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects. Acta Radiol, 2016, 57(6): 733-741

[28] CurrieE, SchulzeA, ZechnerR, et al.. Cellular Fatty Acid Metabolism and Cancer. Cell Metab, 2013, 18(2): 153-161

[29] KobayashiT, LamPY, JiangH, et al.. Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood, 2020, 136(26): 3004-3017

[30] SchollT, MahantaSK, StromingerJL. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. P Natl Acad Sci USA, 1997, 94(12): 6330-6334

[31] ChenDB, XieXW, ZhaoYJ, et al.. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A. Sci Rep, 2020, 10(1): 14538

[32] RimszaL, RobertsR, MillerT, et al.. Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immumosurveillance and poor patient survival: A follow-up study to the NIH director’s challenge leukemia and lymphoma molecular profiling project (LLMPP). Blood, 2004, 103(11): 4251-4258

[33] StewartAJ, SchmidR, BlindauerCA, et al.. Comparative modelling of human PHOSPHO1 reveals a new group of phosphatases within the haloacid dehalogenase superfamily. Protein Eng, 2003, 16(12): 889-895

[34] RobertsSJ, StewartAJ, SadlerPJ, et al.. Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J, 2004, 382: 59-65 Pt 1

[35] HoustonB, SeawrightE, JefferiesD, et al.. Identification and cloning of a novel phosphatase expressed at high levels in differentiating growth plate chondrocytes. Bba-Mol Cell Res, 1999, 1448(3): 500-506

[36] GohilVM, ZhuL, BakerCD, et al.. Meclizine Inhibits Mitochondrial Respiration through Direct Targeting of Cytosolic Phosphoethanolamine Metabolism. J Biolog Chem, 2013, 288(49): 35387-35395

[37] Arias-MendozaF, PayneGS, ZakianK, et al.. Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma. Acad Radiol, 2013, 20(9): 1122-1129

[38] DangCV, O’DonnellKA, ZellerKI, et al.. The c-Myc target gene network. Semin Cancer Biol, 2006, 16(4): 253-264

[39] ZhangJ, MengL, JiangW, et al.. Identification of clinical molecular targets for childhood Burkitt lymphoma. Transl Oncol, 2020, 13(12): 100855

[40] SwerdlowSH, CampoE, PileriSA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 2016, 127(20): 2375-2390

[41] DengM, Xu-MonetteZY, PhamLV, et al.. Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. Mol Cancer Res, 2021, 19(2): 249-260

[42] LouX, FuJ, ZhaoX, et al.. MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages. J Exp Clin Cancer Res, 2020, 39(1): 237

[43] KlapprothK, WirthT. Advances in the understanding of MYC-induced lymphomagenesis. Brit J Haematol, 2010, 149(4): 484-497

[44] MarconatoL, PoltonGA, SabattiniS, et al.. Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature. Vet Comp Oncol, 2017, 15(3): 1029-1040

[45] MarconatoL, FrayssinetP, RouquetN, et al.. Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma. Clin Cancer Res, 2014, 20(3): 668-677

[46] CarboneA, TripodoC, Carlo-StellaC, et al.. The role of inflammation in lymphoma. Adv Exp Med Biol, 2014, 816: 315-333

[47] HowardR, KanetskyPA, EganKM. Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep, 2019, 9(1): 19673

[48] MarconatoL, MartiniV, StefanelloD, et al.. Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy. Vet J, 2015, 206(2): 226-230

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology